Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL
NCT ID: NCT00855491
Last Updated: 2009-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2003-07-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification
NCT01820065
Posterior Capsule Opacification (PCO) With Single Piece Hydrophobic Versus Hydrophillic Intraocular Lens (IOL)
NCT01125345
Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus
NCT01480934
Posterior Capsulotomy in Cataract Complicated With Primary Posterior Capsule Opacification.
NCT03701139
Aphakia Versus Pseudophakia in Children Under 2 Years Undergoing Bilateral Congenital Cataract Surgery
NCT01297153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1. MYOPIA
axial length \> 26.00 mm
Phaco
AcrySof Single-Piece IOL
2. Emmetropia
emmetropic eyes- eyes with an axial length of 21.00 to 23.99 mm
Phaco
AcrySof Single-Piece IOL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phaco
AcrySof Single-Piece IOL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients older than 50 years
* a dilated pupil after mydriasis
* Patients with retinochoroidal atrophy, retinal laser prophylaxis,
* hypertension
Exclusion Criteria
* pseudoexfoliation; mature, traumatic, black, or complicated cataracts;
* previous intraocular surgery;
* previous surgery for glaucoma;
* uveitis
* diabetes mellitus
* Patients who did not give consent preoperatively
50 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iladevi Cataract and IOL Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ICIRC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ALPESH SHAH, MS
Role: PRINCIPAL_INVESTIGATOR
Iladevi Cataract and IOL Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raghudeep Eye Clinic
Ahmedabad, Gujarat, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.